EP0835264A4 - Hcegh45, recepteur de proteines g humaines - Google Patents
Hcegh45, recepteur de proteines g humainesInfo
- Publication number
- EP0835264A4 EP0835264A4 EP95921615A EP95921615A EP0835264A4 EP 0835264 A4 EP0835264 A4 EP 0835264A4 EP 95921615 A EP95921615 A EP 95921615A EP 95921615 A EP95921615 A EP 95921615A EP 0835264 A4 EP0835264 A4 EP 0835264A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hcegh45
- human
- protein receptor
- receptor
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007188 WO1996039439A1 (fr) | 1995-06-06 | 1995-06-06 | Hcegh45, recepteur de proteines g humaines |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0835264A1 EP0835264A1 (fr) | 1998-04-15 |
EP0835264A4 true EP0835264A4 (fr) | 1998-12-30 |
Family
ID=22249263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95921615A Withdrawn EP0835264A4 (fr) | 1995-06-06 | 1995-06-06 | Hcegh45, recepteur de proteines g humaines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0835264A4 (fr) |
JP (1) | JPH11506921A (fr) |
AU (1) | AU2663495A (fr) |
CA (1) | CA2221637A1 (fr) |
WO (1) | WO1996039439A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869632A (en) * | 1995-06-06 | 1999-02-09 | Human Genome Sciences, Inc. | Human G-protein receptor HCEGH45 |
CA2273198A1 (fr) * | 1996-12-02 | 1998-06-11 | Human Genome Sciences, Inc. | Recepteur hcegh45 humain de proteine g, un recepteur de type pacap (de type polypeptide activateur d'adenylate-cyclase hypophisaire) |
US6221627B1 (en) * | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
WO2007113819A2 (fr) | 2006-03-30 | 2007-10-11 | Ben-Gurion University Of The Negev Research And Development Authority | Méthodes et compositions destinés à prévenir et traiter une infection due au streptococcus pneumoniae |
FR2930891B1 (fr) | 2008-05-06 | 2010-09-24 | Biocodex | Composes anti-amnesiants et compositions pharmaceutiques les comprenant |
JP6924148B2 (ja) | 2015-04-16 | 2021-08-25 | ハー・ルンドベック・アクチエゼルスカベット | 抗pacap抗体及びそれらの使用 |
SG11201808630WA (en) | 2016-04-15 | 2018-10-30 | Alder Biopharmaceuticals Inc | Humanized anti-pacap antibodies and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994011504A1 (fr) * | 1992-11-10 | 1994-05-26 | Genentech, Inc. | Recepteur de la chemokine c-c (c-c ckr-1) |
-
1995
- 1995-06-06 CA CA002221637A patent/CA2221637A1/fr not_active Abandoned
- 1995-06-06 AU AU26634/95A patent/AU2663495A/en not_active Abandoned
- 1995-06-06 JP JP9500370A patent/JPH11506921A/ja active Pending
- 1995-06-06 EP EP95921615A patent/EP0835264A4/fr not_active Withdrawn
- 1995-06-06 WO PCT/US1995/007188 patent/WO1996039439A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994011504A1 (fr) * | 1992-11-10 | 1994-05-26 | Genentech, Inc. | Recepteur de la chemokine c-c (c-c ckr-1) |
Non-Patent Citations (2)
Title |
---|
BISHOFF S C ET AL: "RANTES AND RELATED CHEMOKINES ACTIVATE HUMAN BASOPHIL GRANULOCYTES THROUGH DIFFERENT G PROTEIN-COUPLED RECEPTORS", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 23, no. 3, 1 January 1993 (1993-01-01), pages 761 - 767, XP000567783 * |
See also references of WO9639439A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2221637A1 (fr) | 1996-12-12 |
AU2663495A (en) | 1996-12-24 |
EP0835264A1 (fr) | 1998-04-15 |
JPH11506921A (ja) | 1999-06-22 |
WO1996039439A1 (fr) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0815137A4 (fr) | Chemokine recepteur hdgnr10 aux proteines g humaines | |
EP1007536A4 (fr) | Nouveau recepteur couple a la proteine g humaine | |
EP0832125A4 (fr) | Recepteur hgber32 de proteine g humaine | |
EP0828751A4 (fr) | Recepteur de neuropeptides humain | |
HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
AU7692996A (en) | Receptor antagonists | |
EP0817800A4 (fr) | Recepteurs couples par une proteine-g humaine | |
EP0853629A4 (fr) | Recepteur du virus adn de l'hepatite | |
GB9517098D0 (en) | Receptor | |
EP0832122A4 (fr) | Recepteur hpraj70 de proteine g humaine | |
EP0871667A4 (fr) | Recepteur couple a la proteine g | |
EP0835264A4 (fr) | Hcegh45, recepteur de proteines g humaines | |
EP0832126A4 (fr) | Htnad29 recepteurs de proteines g | |
EP0886643A4 (fr) | Recepteur hsatu68 de la chemokine de la proteine g humaine | |
AU8921198A (en) | New human g-protein coupled receptor | |
AU4753496A (en) | Human g-protein coupled receptor | |
HU9600333D0 (en) | Adhesive receptor antagonists | |
EP0812329A4 (fr) | Recepteur couple a la proteine-g humaine | |
EP0792282A4 (fr) | Recepteur pour la bombesine et l'endotheline d'origine humaine | |
EP0836621A4 (fr) | Nouveau recepteur couple a la proteine g humaine | |
EP0833846A4 (fr) | Recepteur couple de proteines g humaines (hetgq23) | |
AU2698995A (en) | G-protein receptor hibeb69 | |
EP0871668A4 (fr) | Hibef51, recepteur de proteines g humaines | |
EP1071766A4 (fr) | PROTEINE G HUMAINE COUPLEE AU RECEPTEUR GPR6sb | |
EP0832124A4 (fr) | Recepteur d'amines humaines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched | ||
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 15/12 |
|
17Q | First examination report despatched |
Effective date: 20010913 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020124 |